UNC and Duke Researchers Collaborate to Predict Drug Safety in Preemies UNC and Duke Researchers Collaborate to Predict Drug Safety in Preemies DPET's Daniel Gonzalez (right) and his Duke collaborator are one of four teams receiving funding for translational research through the Duke/UNC Collaborative Award program. They will explore the safety of using sildenafil to treat pulmonary hypertension in premature infants.
Tumor Microenvironment Is a Rough Neighborhood for Nanoparticle Drugs Tumor Microenvironment Is a Rough Neighborhood for Nanoparticle Drugs A team led by Bill Zamboni, PharmD, PhD, compared the amount of Doxil delivered to two types of breast cancer tumors and were surprised to find one tumor received double the amount of drug as the other. Doxil is a nanoparticle version of the drug doxorubicin.
New Algorithm Increases Success Rate of Drug-Compound Screening New Algorithm Increases Success Rate of Drug-Compound Screening Dmitri Kireev, PhD, has created SPLIF, a new and freely shared algorithm that improves the chances of getting a "hit" from online catalogs of potential lead compounds by four to six times over other computational methods.
Daniel Crona Wins 2014 Katherine A. Brewington Award Daniel Crona Wins 2014 Katherine A. Brewington Award The award recognizes the School’s most outstanding doctoral student in the pharmaceutical sciences.
$100 Million: Eshelman Gift to Fund Innovation Is Largest Ever to a Pharmacy School $100 Million: Eshelman Gift to Fund Innovation Is Largest Ever to a Pharmacy School The gift from alumnus Fred Eshelman will allow the School to pursue high-risk, high-reward ideas with partners on campus and to push those ideas out into the world as advancements in education, pharmacy practice and health care
Research read more graphic
office
UNC Eshelman School of Pharmacy
Office of Economic Development and International Partnerships
CB# 7355
Beard Hall, Room 100F
Chapel Hill, NC 27599-7355